Biogen | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 314.02B 34.8B 2024-12
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
ALKERMES USD 4.65B 123M 2024-12
Amgen USD 140.1B 33.03B 2024-12
Bayer EUR 29.79B 3.87B 2024-09
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
Incyte USD 13.31B 576M 2024-12
Intra Cellular Therapies USD 8.87B 1.14B 2024-12
Merck USD 251.65B 36.21B 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Sanofi EUR 118.41B 10.58B 2024-12
Sanofi USD 145.36B 23.34B 2024-09
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
United Therapeutics USD 15.75B 191M 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Biogen Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.